The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: The EORTC QLQ-BM22

European Journal of Cancer

Volumn 45, Issue 7, 2009, Pages 1146-1152

  Chow, Edward ^a   Hird, Amanda ^a   Velikova, Galina ^b   Johnson, Colin ^c   Dewolf, Linda ^d   Bezjak, Andrea ^e   Wu, Jackson ^f   Shafiq, Jesmin ^g   Sezer, Orhan ^h   Kardamakis, Dimitrios ⁱ   Linden, Yvette van der ^j   Ma, Brigette ^k   Castro, Monica ^l   Arnalot, Palmira Foro ^m   Ahmedzai, Sam ⁿ   Clemons, Mark ^e   Hoskin, Peter ^o   Yee, Albert ^a   Brundage, Michael ^p   Bottomley, Andrew ^d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^d EORTC DATA CENTER   (Belgium)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g LIVERPOOL HOSPITAL   (Australia)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ UNIVERSITY OF PATRAS   (Greece)

^j Radiotherapeutic Institute Friesland   (Netherlands)

^k CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^l UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^m HOSPITAL DE L ESPERANÇA   (Spain)

ⁿ St Lukes Hospice   (United Kingdom)

^o MOUNT VERNON HOSPITAL   (United Kingdom)

^p Cancer Centre of South Eastern Ontario   (Canada)

more..

Author keywords

Bone metastases; Cancer; EORTC; Health related quality of life; Pain symptoms; Questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PATIENT; CLINICAL FEATURE; EUROPE; EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER CORE QUESTIONNAIRE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL PSYCHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; EUROPE; FEMALE; GUIDELINES AS TOPIC; HEALTH STATUS INDICATORS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEOPLASMS; PATIENT PARTICIPATION; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 64449083107     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.11.013     Document Type: Article

References (24)

1. Pain palliation of bone metastases - overview. InSightec.com. InSightec Image Guided Treatment Ltd. 1st April 2005 .
2. Heider U., Fleissner C., Zavrski I., et al. Bone markers in multiple myeloma. Eur J Cancer 42 (2006) 1544-1553
3. Body J., Diel I.J., Bell R., et al. Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer. Pain 111 (2004) 306-312
4. Cresswell S.M., English P.J., Hall R.R., Roberts J.T., and Marsh M.M. Pain relief and quality-of-life assessment following intravenous and oral clodronate in hormone-escaped metastatic prostate cancer. Brit J Urol 76 (1995) 360-365
5. Diel I.J., Body J.J., Lichinitser M.R., et al. Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer. Eur J Cancer 40 (2004) 1704-1712
6. Ernst D.S., Tannock I.F., Winquist E.W., et al. Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain. J Clin Oncol 21 (2003) 3335-3342
7. Fernandez-Conde M., Alcover J., Aaron J.E., Ordi J., and Carretero P. Skeletal response to clodronate in prostate cancer with bone metastases. Am J Clin Oncol 20 (1997) 471-476
8. Kristensen B., Ejlertsen B., Groenvold M., Hein S., Loft H., and Mouridsen H.T. Oral clodronate in breast cancer patients with bone metastases: a randomized study. J Intern Med 246 (1999) 67-74
9. Lipton A., Theriault R.L., Hortobagyi G.N., et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases. Cancer 88 (2000) 1082-1090
10. Mancini I., Dumon J.C., and Body J.J. Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study. J Clin Oncol 22 (2004) 3587-3592
11. Purohit O.P., Anthony C., Radstone C.R., Owen J., and Coleman R.E. High-dose intravenous pamidronate for metastatic bone pain. Brit J Cancer 70 (1994) 554-558
12. Saad F., Gleason D.M., Murray R., et al., Zoledronic Acid Prostate Cancer Study Group. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst 94 (2002) 1458-1468
13. Van Holten-Verzantvoort A.T., Hermans J., Beex L.V., et al. Does supportive pamidronate treatment prevent or delay the first manifestation of bone metastases in breast cancer patients?. Eur J Cancer 32A (1996) 450-454
14. Van Holten-Verzantvoort A.T., Kroon H.M., Bijvoet O.L.M., et al. Palliative pamidronate treatment in patients with bone metastases from breast cancer. J Clin Oncol 11 (1993) 491-498
15. Van Holten-Verzantvoort A.T., Zwinderman A.H., Aaronson N.K., et al. The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. Eur J Cancer 27 (1991) 544-549
16. Wardley A., Davidson N., Barrett-Lee P., et al. Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomized, crossover study of community vs. hospital bisphosphonate administration. Brit J Cancer 92 (2005) 1869-1876
17. World Health Organization. Constitution of the World Health Organization (1948), WHO Basic Documents, Geneva, Switzerland
18. Soni M.K., and Cella D. Quality of life and symptom measures in oncology: an overview. Am J Manage Care 8 (2002) S560-S573
19. Harrington K.D. Prophylactic management of impending fractures. In: Harrington K.D. (Ed). Orthopedic management of metastatic bone disease (1988), CV Mosby 283-307
20. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
21. Sprangers M.A., Cull A., Bjordal K., Groenvold M., and Aaronson N.K. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life. Qual Life Res 2 (1993) 287-295
22. Blazeby J, Sprangers M, Cull A, et al. EORTC Quality of Life Group: guidelines for developing questionnaire modules. 3rd ed. revised. August 2002. .
23. Bottomley A., Vachalec S., Bjordal K., et al. The development and utilization of the European Organisation for research and treatment of cancer quality of life group item bank. Eur J Cancer 38 (2002) 1611-1614
24. Velikova G., Weisb J., Hjermstadc M.J., et al., On behalf of the EORTC Quality of Life Group. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. Eur J Cancer 43 (2007) 87-94